10 | $WSGF News Article - WSGF Previews $10 Million | whytestocks | 12/12/2019 11:45:51 AM |
9 | WSGF 22% v1,1M c.0061 f60M H .0079 | znewcar1 | 09/18/2019 5:31:23 PM |
8 | WSGF 26% v5,3M c.01 f60M EOD Pus | znewcar1 | 08/23/2019 4:36:10 PM |
7 | WSGF 87% v31,4M c.0075 f60,M | znewcar1 | 08/21/2019 4:55:37 PM |
6 | WSGF 53% v26,7M c.0069 f60,0M H .008 | znewcar1 | 08/14/2019 5:46:33 PM |
5 | WSGF 48% v2,1m .007 v60M though it was a | znewcar1 | 07/16/2019 4:35:59 PM |
4 | WSGF 0.0014 L2 0.0011 / 0.0014 | leahanne | 12/09/2014 10:58:26 AM |
3 | WSGF Financials 07/16/2014 05:12:31 World Series | Emylers | 07/16/2014 6:12:27 AM |
2 | WSGF 0.0012 Stock Charts $WSGF 1 Month Chart | chartguy89 | 03/10/2014 7:25:52 PM |
1 | WSGF Stock Charts Last: -0.0004 Sunday, March 2, | chartguy89 | 03/02/2014 10:51:28 AM |
Recent Articles
- Antengene Advances ATG-022: Promising Clinical Outcomes Revealed
- Investigation Announcement for Baxter International Investors
- Cytokinetics Investors: Secure Representation Before Deadline
- Jasper Therapeutics Investors: Important Class Action Deadline Ahead
- Mesoblast Limited Reports Significant Revenue Growth After Ryoncil Launch
- CStone Pharmaceuticals Shares Promising Phase I Results for CS2009
- Ascletis Completes Enrollment in Phase IIa Study of ASC30.
- Innovations in Pancreatic Cancer Treatment with Satri-cel
- Cambodia's Techo International Airport: A Gateway to Growth
- Record Growth in Q2 Revenues Enhances Mesoblast's Market Position
- Faraday Future's Vision: Accelerating Towards FX Super One Launch
- IZERVAY™ Delivers Long-Term Benefits for Geographic Atrophy Patients
- Clover Biopharmaceuticals Names Nicholas Jackson as President
- Dr. Luke Wainscoat Brings Expertise to The Brattle Group
- Kering and L'Oréal Unite to Transform Luxury Beauty Sector
- Kering and L’Oréal: A New Era in Luxury Beauty and Wellness
- Kering Partners with L'Oréal to Transform Luxury Beauty Sector
- Alice Walton and Elon Musk: Giants of Wealth in 2025
- Clarins and V Magazine Host a Glamorous Golden Hour Event
- Sobi Adjusts Revenue Forecast for 2025 Amid Strong Q3 Growth
- Sobi Updates Full-Year Outlook and Q3 2025 Financial Report
- Exploring NB HASH and the Transformation of Wealth Today
- Kevin Hart's Journey From Investment Missteps to Business Success
- BlackRock's Strategic Shift: The Future of Investment in RWA
- Major Contract Termination Announced by Vantage Drilling
- Deadline Approaches for Dow Inc. Investors Amid Legal Action
- Important Update for Cepton, Inc. Investors on Class Action
- Target and Walmart Thrive Amid Collectible Card Sales Surge
- Snap Investors Urged to Consider Leading Legal Action
- Unlocking Wealth Potential: The RWA Revolution Explained
- Embracing Real-World Assets with NB HASH for Sustainable Growth
- Nutex Health Investors Can Join Class Action Against Company
- Potential Legal Action for Baxter International Investors
- Solidarity in Aviation: Airline Workers Support Controllers
- Class Action Lawsuit Against MoonLake Immunotherapeutics Investors
- Promising Outcomes Unveiled from HARMONi-6 Clinical Study
- Exploring Cadonilimab's Promising Results in Advanced Gastric Cancer
- Tech Giants Reshape Manufacturing Strategies Amid Market Shifts
- Promising Findings on Subcutaneous Amivantamab for Cancer
- Vivace Therapeutics Reports Promising Results for VT3989 Therapy
- iOncologi's Patent Enhances Cancer Treatment with mRNA Breakthrough
- Innovative Subcutaneous Therapy Shows Promise in Cancer Treatment
- New Breakthrough Data from Novartis on Prostate Cancer Treatment
- Transforming Assets: The Role of NB HASH in Digital Wealth
- The Future of Wealth: Bridging Real-World Assets with Blockchain
- Avacta Therapeutics Reveals Promising Phase 1a Results for FAP-Dox
- Significant Phase 1a Trial Findings for Faridoxorubicin
- Major Developments in AI: Insights from Top Tech Executives
- Celebrating Five Years of Innovations at United Imaging's Hub
- International Engagement Highlighted at Financial Forum 2025